Skip to main content
. 2021 May 17;71(5):1006–1019. doi: 10.1136/gutjnl-2021-324243

Table 1.

Details of individual patient data included in this meta-analysis

Data set ID Country Study
design
Number of participants (n) Age
(year)
BMI
(kg/m2)
WC
(cm)
M/F Recruitment interval Hardware used Probe used
Agrawal et al 49 UK MC, P, CS 25 47.8
(19–70)
27.7
(15.8–35.7)
95.4
(39–120)
18/7 2009–2012 M
Aykut et al 50 Turkey SC, P, CS 88 46.0
(24–62)
30.3
(18.3–41.8)
101.5
(70–143)
50/38 FibroScan 502 Touch M
Boursier et al 51–53 France MC, P, CS 1063 56.1
(18–83)
31.6
(16.7–55.5)
108.3
(58–174)
613/450 M or XL
Cassinotto et al 54 France SC, P, CS 61 55.9
(22–81)
30.1
(16.7–46.6)
103.6
(72–125)
40/21 2010–2012 M and XL
Cassinotto et al 55 France MC, P, CS 286 56.6
(18–80)
32.2
(20.3–57.4)
109.8
(68–168)
171/115 2011–2015  – M and XL
Chan et al 56 Malaysia SC, P, CS 146 50.4
(18–73)
29.4
(6.9–41.2)
98.3
(79–127)
80/66 2012–2013 FibroScan 502 Touch M
Chan et al 57 Malaysia, Hong Kong MC, P, CC 153 54.0
(24–76)
29.9
(20.1–44.8)
98.4
(69–141)
68/85 FibroScan 502 Touch M and XL
Eddowes et al 31 58 UK MC, P, CS 358 53.3
(19–77)
34.2
(19.5–53.2)
117.2
(65–158)
206/152 M or XL
Eddowes et al 59 UK MC, P, CS 50 50.2
(18–73)
33.6
(23.6–47.8)
109.4
(89–132)
28/22 2014–2015 M or XL
Gaia et al 60 Italy SC, P, CS 68 46.8
(28–65)
28.0
(21.2–40.2)
48/20 2007–2009 M
Garg et al 61 India SC, P, CS 76 38.2
(20–65)
45.2
(32.3–73.8)
16/60 2014–2016 FibroScan 502 Touch XL
Karlas et al 62 Germany SC, P, CS 41 45.7
(28–64)
47.7
(33.7–60.1)
13/28 FibroScan 502 XL
Labenz et al 63 Germany SC, P, CS 126 47.4
(20–73)
31.6
(23.2–50.4)
72/54 FibroScan 402 M or XL
Lee et al 64 Korea SC, P, CS 94 55.5
(19–82)
27.2
(19.1–36.3)
41/53 2014–2015  – M or XL
Lupsor et al 65 Romania SC, P, CS 72 42.4
(20–69)
29.7
(21.0–41.5)
102.4
(60–124)
51/21 2007–2009 M
Mahadeva et al 66 Malaysia SC, P, CS 131 49.9
(23–73)
28.7
(18.6–43.1)
93.5
(43–128)
66/65 2009–2010 M
Okajima et al 67 Japan SC, P, CS 173 56.3
(18–81)
27.2
(16.5–40.3)
84/89 2013–2015  – M
Ooi et al 68 Australia MC, P, CS 82 44.5
(18–67)
46.2
(29.1–74.0)
136.5
(101–192)
23/59 2015–2016 M or XL
Pavlides et al 69 UK SC, P, CS 70 53.5
(25–77)
34.5
(23.0–57.3)
112.5
(80–149)
42/28 2011–2015  – M or XL
Petta et al 70 71 Italy MC, P&R, CS 234 45.5
(15–78)
28.2
(15.7–40.7)
99.4
(69–126)
169/65 2008–2013  – M
Petta et al 28 France, Hong Kong, Italy MC, P, CS 260 54.6
(15–87)
29.4
(16.5–46.6)
100.9
(74–148)
122/138  – M
Petta et al 72 Italy MC, P, CS 474 45.5
(19–77)
29.2
(15.2–49.5)
99.6
(47–164)
275/199  – M
Seki et al 73 Japan SC, P, CS 181 57.7
(16–82)
27.1
(16.9–38.1)
95.1
(71–117)
91/90 2013–2015  – M
Shen et al 74 China MC, P, CS 101 59.0
(16–67)
27.0
(20.1–37.3)
92.9
(75–120)
74/27 2012–2014 FibroScan 502 M
Staufer75 Austria MC, P, CS 186 49.6
(19–83)
32.5
(19.0–56.9)
106/80 2011–2016 FibroScan 502 Touch M or XL
Wong et al 76–79 Hong Kong, France MC, P, CS 464 53.8
(20–83)
30.5
(17.3–48.0)
102.0
(71–148)
201/263 2009–2017  – M and XL
Wong et al 20 Hong Kong, France MC, P, CS 273 51.6
(21–77)
28.8
(16.5–54.0)
96.2
(65–144)
147/126 2003–2009 M
Yoneda et al 80 Japan MC, P, CS 97 52.1
(19–76)
26.5
(17.9–38.5)
41/56 <2008 M
Younes et al 81 Italy MC, P, CS 289 44.8
(15–78)
28.8
(17.5–41.7)
98.9
(47–128)
199/90 M
Ziol et al 82 France SC, P, CS 13 49.3
(39–60)
29.4
(23.8–34.6)
10/3 2003–2005

–, Data not available; BMI, body mass index; CC, case-control; CS, cross-sectional; F, females; M, males; MC, multicentre; P, prospective; R, retrospective; SC, single-centre; WC, waist circumference.

HHS Vulnerability Disclosure